Renee D. Gala, SVP, Chief Financial Officer at Theravance Biopharma, Inc. (TBPH), bought 10,000 shares at $12.19 ($122K) on 2015-08-13, disclosed to the SEC on 2015-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.19 | 5,000 | $61K | 50.1% |
| 2 | $12.16 | 5,000 | $61K | 49.9% |
| Total | $12.18 avg | 10,000 | $122K | 100% |
| Filing → |
| JAZZ | SELL | 2022-12-22 | $422K | — | Filing → |
| TBPH | SELL | 2018-08-16 | $2.3M | — | Filing → |
| TBPH | SELL | 2018-05-22 | $243K | — | Filing → |